Literature DB >> 25897350

Nociception at the diabetic foot, an uncharted territory.

Ernst A Chantelau1.   

Abstract

The diabetic foot is characterised by painless foot ulceration and/or arthropathy; it is a typical complication of painless diabetic neuropathy. Neuropathy depletes the foot skin of intraepidermal nerve fibre endings of the afferent A-delta and C-fibres, which are mostly nociceptors and excitable by noxious stimuli only. However, some of them are cold or warm receptors whose functions in diabetic neuropathy have frequently been reported. Hence, it is well established by quantitative sensory testing that thermal detection thresholds at the foot skin increase during the course of painless diabetic neuropathy. Pain perception (nociception), by contrast, has rarely been studied. Recent pilot studies of pinprick pain at plantar digital skinfolds showed that the perception threshold was always above the upper limit of measurement of 512 mN (equivalent to 51.2 g) at the diabetic foot. However, deep pressure pain perception threshold at musculus abductor hallucis was beyond 1400 kPa (equivalent to 14 kg; limit of measurement) only in every fifth case. These discrepancies of pain perception between forefoot and hindfoot, and between skin and muscle, demand further study. Measuring nociception at the feet in diabetes opens promising clinical perspectives. A critical nociception threshold may be quantified (probably corresponding to a critical number of intraepidermal nerve fibre endings), beyond which the individual risk of a diabetic foot rises appreciably. Staging of diabetic neuropathy according to nociception thresholds at the feet is highly desirable as guidance to an individualised injury prevention strategy.

Entities:  

Keywords:  Amputation; Diabetes mellitus; Diabetic neuropathy; Foot ulcer; Insensitivity to pain; Neuroarthropathy; Pain perception

Year:  2015        PMID: 25897350      PMCID: PMC4398896          DOI: 10.4239/wjd.v6.i3.391

Source DB:  PubMed          Journal:  World J Diabetes        ISSN: 1948-9358


  89 in total

1.  Walking performance in people with diabetic neuropathy: benefits and threats.

Authors:  R V Kanade; R W M van Deursen; K Harding; P Price
Journal:  Diabetologia       Date:  2006-06-07       Impact factor: 10.122

2.  Myelinated nerve endings in human skin.

Authors:  Vincenzo Provitera; Maria Nolano; Angela Pagano; Giuseppe Caporaso; Annamaria Stancanelli; Lucio Santoro
Journal:  Muscle Nerve       Date:  2007-06       Impact factor: 3.217

3.  Can motor nerve conduction velocity predict foot problems in diabetic subjects over a 6-year outcome period?

Authors:  Anne L Carrington; Jonathan E Shaw; Carine H M Van Schie; Caroline A Abbott; Loretta Vileikyte; Andrew J M Boulton
Journal:  Diabetes Care       Date:  2002-11       Impact factor: 19.112

4.  Persisting nutritional neuropathy in former war prisoners.

Authors:  P M Le Quesne
Journal:  Br Med J (Clin Res Ed)       Date:  1983-03-19

5.  The LDIflare: a novel test of C-fiber function demonstrates early neuropathy in type 2 diabetes.

Authors:  Singhan T M Krishnan; Gerry Rayman
Journal:  Diabetes Care       Date:  2004-12       Impact factor: 19.112

6.  Sensory neuropathy and signs of central sensitization in patients with peripheral arterial disease.

Authors:  Philip M Lang; Gabriel M Schober; Roman Rolke; Susanne Wagner; Robert Hilge; Martin Offenbächer; Rolf-Detlef Treede; Ulrich Hoffmann; Dominik Irnich
Journal:  Pain       Date:  2006-05-22       Impact factor: 6.961

7.  Intraepidermal nerve fibers are indicators of small-fiber neuropathy in both diabetic and nondiabetic patients.

Authors:  Gary L Pittenger; Madhumita Ray; Niculina I Burcus; Patricia McNulty; Baher Basta; Aaron I Vinik
Journal:  Diabetes Care       Date:  2004-08       Impact factor: 19.112

8.  Effect of short-term hyperglycemia per se on nociceptive and non-nociceptive thresholds.

Authors:  Peter Thye-Rønn; Søren H Sindrup; Lars Arendt-Nielsen; Jannick Brennum; Ole Hother-Nielsen; Henning Beck-Nielsen
Journal:  Pain       Date:  1994-01       Impact factor: 6.961

9.  Algesic agents exciting muscle nociceptors.

Authors:  S Mense
Journal:  Exp Brain Res       Date:  2009-01-13       Impact factor: 1.972

10.  Reduced vascular endothelial growth factor expression and intra-epidermal nerve fiber loss in human diabetic neuropathy.

Authors:  Cristian Quattrini; Maria Jeziorska; Andrew J M Boulton; Rayaz A Malik
Journal:  Diabetes Care       Date:  2007-10-12       Impact factor: 19.112

View more
  7 in total

1.  Pinprick hypo- and hyperalgesia in diabetic rats: Can diet content affect experimental outcome?

Authors:  Jai Shankar K Yadlapalli; Navdeep Dogra; Anqi W Walbaum; Paul L Prather; Peter A Crooks; Maxim Dobretsov
Journal:  Neurosci Lett       Date:  2018-02-25       Impact factor: 3.046

2.  Conventional deep pressure algometry is not suitable for clinical assessment of nociception in painless diabetic neuropathy.

Authors:  Ernst A Chantelau
Journal:  Diabet Foot Ankle       Date:  2016-09-29

3.  Prevalence and Risk Factors of Sensory Symptoms in Diabetes Patients in Taiwan.

Authors:  Chin-Hsiao Tseng; Choon-Khim Chong; Jau-Jiuan Sheu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-01-08       Impact factor: 5.555

4.  Practices followed by type-II diabetes mellitus patients for prevention of foot ulcers.

Authors:  Vaneet Kaur; C Vasantha Kalyani; Kusum K Rohilla
Journal:  J Family Med Prim Care       Date:  2021-11-05

5.  Patients with type 2 diabetes demonstrate proprioceptive deficit in the knee.

Authors:  Lucas Richard Ettinger; Ami Boucher; Elisabeth Simonovich
Journal:  World J Diabetes       Date:  2018-03-15

6.  Imaging of the spectrum of bony injuries in the diabetic foot: a case series with emphasis on non-Charcot fractures.

Authors:  Marcela Mautone; Parm Naidoo; Kevin Zhou
Journal:  BJR Case Rep       Date:  2017-08-04

7.  Adipose stem cells isolated from diabetic mice improve cutaneous wound healing in streptozotocin-induced diabetic mice.

Authors:  Ran An; Yong Zhang; Yu Qiao; Lili Song; Hongjun Wang; Xiao Dong
Journal:  Stem Cell Res Ther       Date:  2020-03-17       Impact factor: 6.832

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.